Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C097949 |
1,25-dihydroxyvitamin D |
1,25-dihydroxyvitamin D promotes the reaction [VDR protein binds to RXRA protein] | affects binding|increases reaction | 15837528
|
C097949 |
1,25-dihydroxyvitamin D |
1,25-dihydroxyvitamin D results in decreased expression of RXRA mRNA | decreases expression | 15331595
|
C031338 |
13-cis-retinal |
13-cis-retinal promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] | affects binding|increases expression|increases reaction | 16632523
|
C028474 |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with alitretinoin] promotes the reaction [[NR1I3 protein binds to RXRA protein] which binds to NCOA1 protein] | affects binding|affects cotreatment|increases reaction | 17223708
|
C028474 |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [[NR1I3 protein binds to RXRA protein] which binds to NCOA1 protein] | affects binding|increases reaction | 17223708
|
C097240 |
15-deoxy-delta(12,14)-prostaglandin J2 |
15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of RXRA | increases expression | 15254749
|
C483845 |
2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid |
RXRA protein results in increased susceptibility to 2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid | increases response to substance | 17259670
|
C022776 |
2-bromopalmitate |
2-bromopalmitate results in increased activity of [RXRA protein binds to PPARD protein] | affects binding|increases activity | 15997096
|
C054189 |
3,5-di-tert-butylchalcone 4'-carboxylic acid |
3,5-di-tert-butylchalcone 4'-carboxylic acid results in increased expression of RXRA mRNA | increases expression | 7556191
|
C034534 |
3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid |
[Vitamin K 2 co-treated with 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid] results in decreased phosphorylation of RXRA protein | affects cotreatment|decreases phosphorylation | 17270033
|
C034534 |
3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid |
3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid results in decreased phosphorylation of RXRA protein | decreases phosphorylation | 21071580
|
C038864 |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of RXRA mRNA | decreases expression | 15583048
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of RXRA mRNA | increases expression | 18648102
|
C041594 |
4-nonylphenol |
4-nonylphenol results in decreased expression of RXRA mRNA | decreases expression | 16013040
|
C031390 |
9-cis-retinal |
9-cis-retinal promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] | affects binding|increases expression|increases reaction | 16632523
|
C037112 |
9-deoxy-delta-9-prostaglandin D2 |
[9-deoxy-delta-9-prostaglandin D2 co-treated with alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter] | affects binding|affects cotreatment|increases reaction | 15150131
|
D000082 |
Acetaminophen |
RXRA protein promotes the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | increases expression|increases reaction | 14978233
|
D000082 |
Acetaminophen |
RXRA protein promotes the reaction [Acetaminophen results in increased expression of CYP3A11 mRNA] | increases expression|increases reaction | 14978233
|
D000082 |
Acetaminophen |
RXRA protein results in increased susceptibility to Acetaminophen | increases response to substance | 14978233
|
C430898 |
AGN 194204 |
AGN 194204 binds to and results in increased activity of RXRA protein | affects binding|increases activity | 16178010
|
C430898 |
AGN 194204 |
RXRA protein results in increased susceptibility to AGN 194204 | increases response to substance | 15318936
|
C103303 |
alitretinoin |
alitretinoin binds to and results in increased activity of RXRA protein | affects binding|increases activity | 7565671
|
C103303 |
alitretinoin |
[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with alitretinoin] promotes the reaction [[NR1I3 protein binds to RXRA protein] which binds to NCOA1 protein] | affects binding|affects cotreatment|increases reaction | 17223708
|
C103303 |
alitretinoin |
alitretinoin affects the localization of RXRA protein | affects localization | 17170071
|
C103303 |
alitretinoin |
alitretinoin analog binds to and results in increased activity of RXRA protein | affects binding|increases activity | 16946489
|
C103303 |
alitretinoin |
alitretinoin binds to and affects the activity of RXRA protein | affects activity|affects binding | 15941851
|
C103303 |
alitretinoin |
alitretinoin binds to and results in increased activity of RXRA protein | affects binding|increases activity | 16946489 15866424
|
C103303 |
alitretinoin |
[alitretinoin binds to and results in increased activity of RXRA protein] which results in increased expression of CYP19A1 protein | affects binding|increases activity|increases expression | 15941851
|
C103303 |
alitretinoin |
[alitretinoin co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] affects the localization of RXRA protein | affects cotreatment|affects localization | 17170071
|
C103303 |
alitretinoin |
[alitretinoin co-treated with Calcitriol] results in increased stability of [RXRA protein binds to VDR protein] | affects binding|affects cotreatment|increases stability | 16204233
|
C103303 |
alitretinoin |
[alitretinoin co-treated with RXRA protein] results in increased expression of PSG5 mRNA | affects cotreatment|increases expression | 17475324
|
C103303 |
alitretinoin |
alitretinoin inhibits the reaction [triphenyltin hydroxide binds to RXRA protein] | affects binding|decreases reaction | 15941851
|
C103303 |
alitretinoin |
alitretinoin promotes the reaction [[NR1I3 protein binds to RXRA protein] which binds to NCOA1 protein] | affects binding|increases reaction | 17223708
|
C103303 |
alitretinoin |
alitretinoin promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] | affects binding|increases expression|increases reaction | 16632523
|
C103303 |
alitretinoin |
alitretinoin results in decreased expression of RXRA protein | decreases expression | 15375546
|
C103303 |
alitretinoin |
[alitretinoin results in increased activity of RXRA protein] which binds to PSG5 promoter | affects binding|increases activity | 17475324
|
C103303 |
alitretinoin |
alitretinoin results in increased degradation of RXRA protein | increases degradation | 17170071
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of RXRA mRNA | increases expression | 11139446
|
C103303 |
alitretinoin |
alitretinoin results in increased ubiquitination of RXRA protein | increases ubiquitination | 17170071
|
C103303 |
alitretinoin |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [alitretinoin results in increased degradation of RXRA protein] | decreases reaction|increases degradation | 17170071
|
C103303 |
alitretinoin |
[pirinixic acid co-treated with alitretinoin co-treated with PPARA protein co-treated with RXRA protein] results in decreased expression of UGDH mRNA | affects cotreatment|decreases expression | 16292757
|
C103303 |
alitretinoin |
RXRA protein binds to alitretinoin | affects binding | 16460010
|
C103303 |
alitretinoin |
tributyltin inhibits the reaction [alitretinoin binds to RXRA protein] | affects binding|decreases reaction | 15941851
|
C103303 |
alitretinoin |
triphenyltin chloride inhibits the reaction [alitretinoin binds to RXRA protein] | affects binding|decreases reaction | 15941851
|
C103303 |
alitretinoin |
triphenyltin hydroxide inhibits the reaction [alitretinoin binds to RXRA protein] | affects binding|decreases reaction | 15941851
|
C103303 |
alitretinoin |
alitretinoin binds to and results in increased activity of RXRA protein | affects binding|increases activity | 17084873
|
C103303 |
alitretinoin |
alitretinoin binds to [RXRA protein binds to RARB protein] | affects binding | 15159591
|
C103303 |
alitretinoin |
alitretinoin inhibits the reaction [TGIF1 protein binds to RXRA protein] | affects binding|decreases reaction | 16428452
|
C103303 |
alitretinoin |
alitretinoin inhibits the reaction [TGIF1 protein results in increased activity of RXRA protein] | decreases reaction|increases activity | 16428452
|
C103303 |
alitretinoin |
alitretinoin results in increased activity of [RXRA protein binds to RXRA protein] | affects binding|increases activity | 15997096
|
C103303 |
alitretinoin |
alitretinoin results in increased localization of RXRA protein | increases localization | 16204233
|
C103303 |
alitretinoin |
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate inhibits the reaction [alitretinoin results in increased activity of [RXRA protein binds to RXRA protein]] | affects binding|decreases reaction|increases activity | 15997096
|
C103303 |
alitretinoin |
RXRA protein promotes the reaction [alitretinoin results in increased expression of PPARGC1A mRNA] | increases expression|increases reaction | 16513826
|
C103303 |
alitretinoin |
[9-deoxy-delta-9-prostaglandin D2 co-treated with alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter] | affects binding|affects cotreatment|increases reaction | 15150131
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of RXRA protein | increases expression | 16043492
|
C103303 |
alitretinoin |
alitretinoin results in increased activity of RXRA protein | increases activity | 15178767
|
C103303 |
alitretinoin |
alitretinoin binds to and results in increased activity of RXRA protein | affects binding|increases activity | 16037943
|
C103303 |
alitretinoin |
alitretinoin binds to [PPARG protein binds to RXRA protein] | affects binding | 10882139
|
C103303 |
alitretinoin |
alitretinoin binds to RXRA protein | affects binding | 17387344
|
D024502 |
alpha-Tocopherol |
[Tretinoin co-treated with alpha-Tocopherol co-treated with Okadaic Acid] results in decreased phosphorylation of RXRA protein | affects cotreatment|decreases phosphorylation | 15225641
|
D024502 |
alpha-Tocopherol |
[Tretinoin co-treated with alpha-Tocopherol] results in decreased phosphorylation of RXRA protein | affects cotreatment|decreases phosphorylation | 15225641
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of RXRA mRNA | affects expression | 16483693
|
D000841 |
Anisomycin |
Anisomycin results in increased phosphorylation of RXRA protein | increases phosphorylation | 16038797
|
D000841 |
Anisomycin |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Anisomycin results in increased phosphorylation of RXRA protein] | decreases reaction|increases phosphorylation | 16038797
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Anisomycin results in increased phosphorylation of RXRA protein] | decreases reaction|increases phosphorylation | 16038797
|
D016590 |
Aphidicolin |
Aphidicolin results in increased expression of RXRA mRNA | increases expression | 14738865
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of RXRA mRNA | increases expression | 19769630
|
C006632 |
arsenic trioxide |
arsenic trioxide inhibits the reaction [RXRA protein binds to PPARG protein] | affects binding|decreases reaction | 15916724
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of RXRA protein | decreases expression | 15916724
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased phosphorylation of RXRA protein | increases phosphorylation | 15688020
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of RXRA mRNA | affects expression | 17331233
|
D001554 |
Benzene |
Benzene results in increased expression of RXRA mRNA | increases expression | 15878777
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [RXRA protein binds to CYP24A1 promoter]] | affects binding|decreases reaction|increases reaction | 19244278
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of RXRA mRNA | decreases expression | 20064835
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RXRA mRNA | decreases expression | 19150397
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
[alitretinoin co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] affects the localization of RXRA protein | affects cotreatment|affects localization | 17170071
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [alitretinoin results in increased degradation of RXRA protein] | decreases reaction|increases degradation | 17170071
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased degradation of RXRA protein] | decreases degradation|decreases reaction | 12970875
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased stability of and results in increased expression of RXRA protein | increases expression|increases stability | 15707588
|
D019207 |
beta Carotene |
beta Carotene promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] | affects binding|increases expression|increases reaction | 16632523
|
D001647 |
Bile Acids and Salts |
RXRA protein promotes the reaction [pirinixic acid results in increased abundance of Bile Acids and Salts] | increases abundance|increases reaction | 19176532
|
C070515 |
bisindolylmaleimide I |
[Tretinoin co-treated with bisindolylmaleimide I] results in decreased phosphorylation of RXRA protein | affects cotreatment|decreases phosphorylation | 15225641
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of RXRA mRNA | decreases expression | 14967906
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of RXRA mRNA | increases expression | 15738621 14967906
|
D020122 |
tert-Butylhydroperoxide |
RXRA protein results in decreased susceptibility to tert-Butylhydroperoxide | decreases response to substance | 14978233
|
C058819 |
calphostin C |
[Tretinoin co-treated with calphostin C] results in decreased phosphorylation of RXRA protein | affects cotreatment|decreases phosphorylation | 15225641
|
D002211 |
Capsaicin |
Capsaicin results in decreased expression of RXRA mRNA | decreases expression | 18769453
|
C505748 |
CD4528 |
CD4528 promotes the reaction [VDR protein binds to RXRA protein] | affects binding|increases reaction | 15860548
|
D002994 |
Clofibrate |
Clofibrate results in increased stability of RXRA protein | increases stability | 12753917
|
D002995 |
Clofibric Acid |
Clofibric Acid results in increased expression of RXRA protein | increases expression | 15670589
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of RXRA mRNA | increases expression | 19022236
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of RXRA protein | increases expression | 15965953
|
C438269 |
diazepinylbenzoic acid |
diazepinylbenzoic acid binds to and results in decreased activity of RXRA protein | affects binding|decreases activity | 19095448
|
D004041 |
Dietary Fats |
Dietary Fats affects the expression of RXRA mRNA | affects expression | 16079505
|
D002117 |
Calcitriol |
[alitretinoin co-treated with Calcitriol] results in increased stability of [RXRA protein binds to VDR protein] | affects binding|affects cotreatment|increases stability | 16204233
|
D002117 |
Calcitriol |
Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [RXRA protein binds to CYP24A1 promoter]] | affects binding|decreases reaction|increases reaction | 19244278
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [RXRA protein binds to CYP24A1 promoter] | affects binding|increases reaction | 19244278
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [[VDR protein binds to RXRA protein] which binds to CYP24A1 promoter] | affects binding|increases reaction | 15919092
|
D002117 |
Calcitriol |
Calcitriol affects the expression of RXRA protein | affects expression | 16368784
|
D002117 |
Calcitriol |
Calcitriol affects the localization of RXRA protein | affects localization | 15647825
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [RXRA protein binds to CYP24A1 promoter] | affects binding|increases reaction | 15647825
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [RXRA protein binds to SPP1 promoter] | affects binding|increases reaction | 15647825
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [[VDR protein binds to RXRA protein] which binds to CYP24A1 promoter] | affects binding|increases reaction | 15992766
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [[VDR protein binds to RXRA protein] which binds to CYP3A4 promoter] | affects binding|increases reaction | 15992766
|
C472511 |
dimethylarsinous acid |
dimethylarsinous acid results in increased expression of RXRA mRNA | increases expression | 19084030
|
D004121 |
Dimethyl Sulfoxide |
Dimethyl Sulfoxide results in increased expression of RXRA mRNA | increases expression | 9751115
|
D004121 |
Dimethyl Sulfoxide |
Dimethyl Sulfoxide results in increased expression of RXRA protein | increases expression | 9751115
|
D004121 |
Dimethyl Sulfoxide |
RXRA protein affects the susceptibility to Dimethyl Sulfoxide | affects response to substance | 9751115
|
D004281 |
Docosahexaenoic Acids |
Docosahexaenoic Acids binds to and results in increased activity of RXRA protein | affects binding|increases activity | 12844485
|
D004281 |
Docosahexaenoic Acids |
Docosahexaenoic Acids binds to and results in increased activity of RXRA protein | affects binding|increases activity | 12844485
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of RXRA mRNA | decreases expression | 16872691
|
C504648 |
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate |
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate inhibits the reaction [alitretinoin results in increased activity of [RXRA protein binds to RXRA protein]] | affects binding|decreases reaction|increases activity | 15997096
|
C504648 |
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate |
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate results in increased activity of [RXRA protein binds to PPARA protein] | affects binding|increases activity | 15997096
|
C504648 |
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate |
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate results in increased activity of [RXRA protein binds to PPARD protein] | affects binding|increases activity | 15997096
|
C504648 |
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate |
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate results in increased activity of [RXRA protein binds to PPARG protein] | affects binding|increases activity | 15997096
|
C504648 |
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate |
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate results in increased activity of [RXRA protein binds to RXRA protein] | affects binding|increases activity | 15997096
|
D017308 |
Etodolac |
Etodolac binds to and results in decreased activity of RXRA protein | affects binding|decreases activity | 15699354
|
D017308 |
Etodolac |
Etodolac results in increased degradation of RXRA protein | increases degradation | 15699354
|
C422415 |
farglitazar |
farglitazar binds to [PPARG protein binds to RXRA protein] | affects binding | 10882139
|
D015525 |
Fatty Acids, Omega-3 |
Fatty Acids, Omega-3 results in increased expression of RXRA mRNA | increases expression | 12844485
|
D005231 |
Fatty Acids, Unsaturated |
Fatty Acids, Unsaturated results in increased expression of RXRA mRNA | increases expression | 16571146
|
D005978 |
Glutathione |
GCLC protein affects the reaction [RXRA protein affects the abundance of Glutathione] | affects abundance|affects reaction | 14978233
|
D005978 |
Glutathione |
RXRA protein affects the abundance of Glutathione | affects abundance | 14978233
|
D006118 |
Griseofulvin |
Griseofulvin results in decreased expression of RXRA mRNA | decreases expression | 9548566
|
C120099 |
GW 1929 |
GW 1929 results in increased activity of [PPARG protein binds to RXRA protein] | affects binding|increases activity | 20008677
|
C120099 |
GW 1929 |
ZNF366 protein promotes the reaction [GW 1929 results in increased activity of [PPARG protein binds to RXRA protein]] | affects binding|increases activity|increases reaction | 20008677
|
D017313 |
Fenretinide |
Fenretinide promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] | affects binding|increases expression|increases reaction | 16632523
|
D017313 |
Fenretinide |
Fenretinide results in decreased expression of RXRA protein | decreases expression | 15375546
|
D017313 |
Fenretinide |
Fenretinide results in increased expression of RXRA mRNA | increases expression | 16570282
|
D007213 |
Indomethacin |
[L 663536 co-treated with Indomethacin] results in increased expression of RXRA mRNA | affects cotreatment|increases expression | 15899809
|
C060893 |
L 663536 |
[L 663536 co-treated with Indomethacin] results in increased expression of RXRA mRNA | affects cotreatment|increases expression | 15899809
|
C060893 |
L 663536 |
L 663536 results in increased expression of RXRA mRNA | increases expression | 15899809
|
C095104 |
LG 100268 |
LG 100268 binds to and results in increased activity of RXRA protein | affects binding|increases activity | 12519787
|
C095104 |
LG 100268 |
[LG 100268 binds to and results in increased activity of RXRA protein] which results in increased expression of CYP19A1 protein | affects binding|increases activity|increases expression | 15941851
|
C095104 |
LG 100268 |
LG 100268 inhibits the reaction [[NR1H4 protein binds to RXRA protein] which binds to ABCB11 promoter] | affects binding|decreases reaction | 12519787
|
C095104 |
LG 100268 |
LG 100268 results in increased activity of RXRA protein | increases activity | 15544927
|
C095104 |
LG 100268 |
LG 100268 results in increased activity of RXRA protein alternative form | increases activity | 15544927
|
C423914 |
LG 268 |
LG 268 results in increased activity of RXRA protein | increases activity | 15178767
|
C423914 |
LG 268 |
LG 268 promotes the reaction [NCOA3 protein binds to [RXRA protein binds to RXRA protein]] | affects binding|increases reaction | 15310754
|
D001556 |
Lindane |
Lindane affects the expression of RXRA mRNA | affects expression | 17785943
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased activity of RXRA protein | decreases activity | 12388159
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of RXRA mRNA | decreases expression | 16847310 12388159
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of RXRA protein | decreases expression | 16002565 12388159 16847310
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased localization of RXRA protein | decreases localization | 15312234
|
D008095 |
Lithocholic Acid |
Lithocholic Acid promotes the reaction [VDR protein binds to RXRA protein] | affects binding|increases reaction | 15824121
|
D008095 |
Lithocholic Acid |
Lithocholic Acid promotes the reaction [[VDR protein binds to RXRA protein] which binds to CYP24A1 promoter] | affects binding|increases reaction | 15992766
|
D008095 |
Lithocholic Acid |
Lithocholic Acid promotes the reaction [[VDR protein binds to RXRA protein] which binds to CYP3A4 promoter] | affects binding|increases reaction | 15992766
|
D008095 |
Lithocholic Acid |
Lithocholic Acid promotes the reaction [[VDR protein binds to RXRA protein] which results in increased expression of ABCC3] | affects binding|increases expression|increases reaction | 15824121
|
D008095 |
Lithocholic Acid |
Lithocholic Acid promotes the reaction [[VDR protein binds to RXRA protein] which results in increased expression of CYP3A11] | affects binding|increases expression|increases reaction | 15824121
|
D008095 |
Lithocholic Acid |
Lithocholic Acid promotes the reaction [[VDR protein binds to RXRA protein] which results in increased expression of SULT2A2] | affects binding|increases expression|increases reaction | 15824121
|
D008701 |
Methapyrilene |
Methapyrilene results in decreased expression of RXRA mRNA | decreases expression | 17450226
|
C423917 |
MG 262 |
MG 262 results in increased stability of and results in increased expression of RXRA protein | increases expression|increases stability | 15707588
|
C007350 |
nitrofen |
nitrofen results in increased expression of RXRA mRNA | increases expression | 17270546
|
D019319 |
Okadaic Acid |
[Tretinoin co-treated with alpha-Tocopherol co-treated with Okadaic Acid] results in decreased phosphorylation of RXRA protein | affects cotreatment|decreases phosphorylation | 15225641
|
C484027 |
oligofectamine |
oligofectamine results in decreased expression of RXRA mRNA | decreases expression | 14668052
|
D009963 |
Orotic Acid |
[Sucrose co-treated with Orotic Acid] results in decreased expression of RXRA protein | affects cotreatment|decreases expression | 15670589
|
D010269 |
Paraquat |
Paraquat results in decreased expression of RXRA mRNA | decreases expression | 16797015
|
C023036 |
perfluorooctanoic acid |
RXRA protein results in increased susceptibility to perfluorooctanoic acid | increases response to substance | 17259670
|
D010634 |
Phenobarbital |
Phenobarbital affects the expression of RXRA mRNA | affects expression | 16510358
|
C006253 |
pirinixic acid |
[pirinixic acid co-treated with alitretinoin co-treated with PPARA protein co-treated with RXRA protein] results in decreased expression of UGDH mRNA | affects cotreatment|decreases expression | 16292757
|
C006253 |
pirinixic acid |
pirinixic acid promotes the reaction [[PPARA protein co-treated with RXRA protein] results in increased expression of IL1RN mRNA] | affects cotreatment|increases expression|increases reaction | 17321000
|
C006253 |
pirinixic acid |
pirinixic acid results in increased activity of [RXRA protein binds to PPARA protein] | affects binding|increases activity | 15997096
|
C006253 |
pirinixic acid |
RXRA protein affects the reaction [pirinixic acid results in increased expression of ABCC3 mRNA] | affects reaction|increases expression | 19176532
|
C006253 |
pirinixic acid |
RXRA protein inhibits the reaction [pirinixic acid results in decreased expression of SLCO1A1 mRNA] | decreases expression|decreases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein inhibits the reaction [pirinixic acid results in increased expression of CYP3A11 mRNA] | decreases reaction|increases expression | 19176532
|
C006253 |
pirinixic acid |
RXRA protein inhibits the reaction [pirinixic acid results in increased expression of CYP3A11 protein] | decreases reaction|increases expression | 19176532
|
C006253 |
pirinixic acid |
RXRA protein inhibits the reaction [pirinixic acid results in increased expression of NR0B2 mRNA] | decreases reaction|increases expression | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in decreased expression of WEE1 protein] | decreases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased abundance of Bile Acids and Salts] | increases abundance|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of ACOX1 mRNA] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of ACOX1 protein] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of ALPL protein] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of CCNA2 mRNA] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of CCNB1 mRNA] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of CCND1 mRNA] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of CCND1 protein] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of CCND3 mRNA] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of CCND3 protein] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of CDK1 mRNA] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of CDK1 protein] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of IL1B mRNA] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein promotes the reaction [pirinixic acid results in increased expression of PCNA protein] | increases expression|increases reaction | 19176532
|
C006253 |
pirinixic acid |
RXRA protein results in increased susceptibility to pirinixic acid | increases response to substance | 19176532
|
C443641 |
poly(propyleneimine) |
poly(propyleneimine) analog results in increased expression of RXRA mRNA | increases expression | 16308212
|
D011374 |
Progesterone |
Progesterone results in decreased expression of RXRA mRNA | decreases expression | 18037150
|
D015474 |
Isotretinoin |
Isotretinoin promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] | affects binding|increases expression|increases reaction | 16632523
|
D012176 |
Retinoids |
Retinoids analog binds to and results in increased activity of RXRA protein | affects binding|increases activity | 16364638
|
C009166 |
retinol acetate |
retinol acetate results in increased expression of RXRA mRNA | increases expression | 16772331
|
D012293 |
Rifampin |
[Rifampin co-treated with PPARA protein co-treated with RXRA protein] results in decreased expression of UGDH mRNA | affects cotreatment|decreases expression | 16292757
|
D012293 |
Rifampin |
Rifampin promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] | affects binding|increases expression|increases reaction | 16632523
|
C089730 |
rosiglitazone |
rosiglitazone results in increased expression of RXRA | increases expression | 15254749
|
C089730 |
rosiglitazone |
[PPARG protein co-treated with RXRA protein] promotes the reaction [rosiglitazone results in increased expression of PPARGC1A mRNA] | affects cotreatment|increases expression|increases reaction | 16513826
|
C089730 |
rosiglitazone |
rosiglitazone results in increased activity of [RXRA protein binds to PPARG protein] | affects binding|increases activity | 15997096
|
C089730 |
rosiglitazone |
rosiglitazone binds to [PPARG protein binds to RXRA protein] | affects binding | 10882139
|
C089730 |
rosiglitazone |
[rosiglitazone binds to PPARG protein] which binds to RXRA protein | affects binding | 15715931
|
D012643 |
Selenium |
Selenium results in increased expression of RXRA protein | increases expression | 15318950
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of RXRA mRNA | decreases expression | 15833926
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of RXRA protein | decreases expression | 15833926
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of RXRA mRNA | increases expression | 19084030
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of RXRA mRNA | decreases expression | 19822182
|
D013395 |
Sucrose |
[Sucrose co-treated with Orotic Acid] results in decreased expression of RXRA protein | affects cotreatment|decreases expression | 15670589
|
C033006 |
sudan III |
sudan III results in decreased expression of RXRA protein | decreases expression | 15585952
|
D013449 |
Sulfonamides |
Sulfonamides analog binds to and results in decreased activity of RXRA protein | affects binding|decreases activity | 19095448
|
D013449 |
Sulfonamides |
Sulfonamides analog binds to and results in increased activity of RXRA protein | affects binding|increases activity | 19095448
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of RXRA mRNA | decreases expression | 18336851
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of RXRA mRNA | increases expression | 19684285 20106945 15075337
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of RXRA mRNA | decreases expression | 17586704
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of RXRA mRNA | increases expression | 15667827
|
D013755 |
Tetradecanoylphorbol Acetate |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased degradation of RXRA protein] | decreases degradation|decreases reaction | 12970875
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in decreased degradation of RXRA protein | decreases degradation | 12970875
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in decreased localization of RXRA protein | decreases localization | 12970875
|
D014212 |
Tretinoin |
[RARA protein binds to RXRA protein] promotes the reaction [Tretinoin results in increased degradation of NCOA3 protein] | affects binding|increases degradation|increases reaction | 16456540
|
D014212 |
Tretinoin |
RXRA protein promotes the reaction [Tretinoin results in increased expression of SOX3 mRNA] | increases expression|increases reaction | 17005281
|
D014212 |
Tretinoin |
RXRA protein promotes the reaction [Tretinoin results in increased expression of SOX3 protein] | increases expression|increases reaction | 17005281
|
D014212 |
Tretinoin |
Tretinoin affects the localization of RXRA protein | affects localization | 16636311
|
D014212 |
Tretinoin |
Tretinoin analog binds to and results in increased activity of RXRA protein | affects binding|increases activity | 16946489
|
D014212 |
Tretinoin |
Tretinoin binds to and results in increased activity of RXRA protein | affects binding|increases activity | 16946489
|
D014212 |
Tretinoin |
Tretinoin binds to [RXRA protein binds to RARA protein] | affects binding | 16757381
|
D014212 |
Tretinoin |
[Tretinoin binds to [RXRA protein binds to RARA protein]] which binds to PDK4 promoter | affects binding | 16757381
|
D014212 |
Tretinoin |
[Tretinoin co-treated with alpha-Tocopherol co-treated with Okadaic Acid] results in decreased phosphorylation of RXRA protein | affects cotreatment|decreases phosphorylation | 15225641
|
D014212 |
Tretinoin |
[Tretinoin co-treated with alpha-Tocopherol] results in decreased phosphorylation of RXRA protein | affects cotreatment|decreases phosphorylation | 15225641
|
D014212 |
Tretinoin |
[Tretinoin co-treated with bisindolylmaleimide I] results in decreased phosphorylation of RXRA protein | affects cotreatment|decreases phosphorylation | 15225641
|
D014212 |
Tretinoin |
[Tretinoin co-treated with calphostin C] results in decreased phosphorylation of RXRA protein | affects cotreatment|decreases phosphorylation | 15225641
|
D014212 |
Tretinoin |
[Tretinoin co-treated with RARA protein co-treated with RXRA protein] results in increased expression of CYP26A1 mRNA | affects cotreatment|increases expression | 17244623
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [[RARA protein binds to RXRA protein] which binds to NOS2A promoter] | affects binding|increases reaction | 17306764
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [RXRA protein binds to CD1D promoter] | affects binding|increases reaction | 17392484
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] | affects binding|increases expression|increases reaction | 16632523
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of RXRA protein | decreases expression | 15194426 15375546
|
D014212 |
Tretinoin |
Tretinoin results in decreased phosphorylation of RXRA protein | decreases phosphorylation | 15126328
|
D014212 |
Tretinoin |
Tretinoin results in increased activity of [RARA protein binds to RXRA protein] | affects binding|increases activity | 20008677
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of and results in increased activity of RXRA protein | increases activity|increases expression | 16158052
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of RXRA mRNA | increases expression | 7556191 16517099
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of RXRA protein | increases expression | 16636311 17005281
|
D014212 |
Tretinoin |
Tretinoin results in increased phosphorylation of RXRA protein | increases phosphorylation | 15225641
|
D014212 |
Tretinoin |
ZNF366 protein promotes the reaction [Tretinoin results in increased activity of [RARA protein binds to RXRA protein]] | affects binding|increases activity|increases reaction | 20008677
|
D014212 |
Tretinoin |
[Tretinoin binds to RXRA protein] which binds to NRL promoter | affects binding | 16854989
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [[RARG protein binds to RXRA protein] which binds to CYP26A1 promoter] | affects binding|increases reaction | 16053444
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of RXRA protein | decreases expression | 15646024
|
D014212 |
Tretinoin |
Tretinoin affects the localization of RXRA protein | affects localization | 17078027
|
D014212 |
Tretinoin |
Tretinoin results in increased activity of RXRA protein | increases activity | 15178767
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of RXRA mRNA | increases expression | 1312717
|
C011559 |
tributyltin |
[tributyltin binds to and results in increased activity of RXRA protein] which results in increased expression of CYP19A1 protein | affects binding|increases activity|increases expression | 15941851
|
C011559 |
tributyltin |
tributyltin inhibits the reaction [alitretinoin binds to RXRA protein] | affects binding|decreases reaction | 15941851
|
C011559 |
tributyltin |
tributyltin inhibits the reaction [triphenyltin hydroxide binds to RXRA protein] | affects binding|decreases reaction | 15941851
|
C012594 |
triphenyltin chloride |
triphenyltin chloride inhibits the reaction [alitretinoin binds to RXRA protein] | affects binding|decreases reaction | 15941851
|
C012594 |
triphenyltin chloride |
triphenyltin chloride inhibits the reaction [triphenyltin hydroxide binds to RXRA protein] | affects binding|decreases reaction | 15941851
|
C007567 |
triphenyltin hydroxide |
alitretinoin inhibits the reaction [triphenyltin hydroxide binds to RXRA protein] | affects binding|decreases reaction | 15941851
|
C007567 |
triphenyltin hydroxide |
tributyltin inhibits the reaction [triphenyltin hydroxide binds to RXRA protein] | affects binding|decreases reaction | 15941851
|
C007567 |
triphenyltin hydroxide |
triphenyltin chloride inhibits the reaction [triphenyltin hydroxide binds to RXRA protein] | affects binding|decreases reaction | 15941851
|
C007567 |
triphenyltin hydroxide |
triphenyltin hydroxide binds to and affects the activity of RXRA protein | affects activity|affects binding | 15941851
|
C007567 |
triphenyltin hydroxide |
[triphenyltin hydroxide binds to and results in increased activity of RXRA protein] which results in increased expression of CYP19A1 protein | affects binding|increases activity|increases expression | 15941851
|
C007567 |
triphenyltin hydroxide |
triphenyltin hydroxide inhibits the reaction [alitretinoin binds to RXRA protein] | affects binding|decreases reaction | 15941851
|
C057693 |
troglitazone |
troglitazone results in increased activity of [PPARG protein binds to RXRA protein] | affects binding|increases activity | 20008677
|
C057693 |
troglitazone |
ZNF366 protein promotes the reaction [troglitazone results in increased activity of [PPARG protein binds to RXRA protein]] | affects binding|increases activity|increases reaction | 20008677
|
C057693 |
troglitazone |
[troglitazone binds to PPARG protein] which binds to RXRA protein | affects binding | 15715931
|
D014501 |
Uranium |
Uranium results in decreased expression of RXRA mRNA | decreases expression | 17118558
|
D014801 |
Vitamin A |
Vitamin A results in increased expression of RXRA mRNA | increases expression | 16571146
|
D014801 |
Vitamin A |
[Vitamin A co-treated with RARA protein co-treated with RXRA protein] results in increased expression of CYP26A1 mRNA | affects cotreatment|increases expression | 17244623
|
D014801 |
Vitamin A |
Vitamin A results in increased expression of RXRA protein | increases expression | 17219422
|
D014801 |
Vitamin A |
Vitamin A results in increased expression of RXRA mRNA | increases expression | 16180333
|
D024482 |
Vitamin K 2 |
[Vitamin K 2 co-treated with 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid] results in decreased phosphorylation of RXRA protein | affects cotreatment|decreases phosphorylation | 17270033
|
D024482 |
Vitamin K 2 |
Vitamin K 2 results in decreased phosphorylation of RXRA protein | decreases phosphorylation | 17270033
|
D015054 |
Zymosan |
Zymosan results in decreased expression of RXRA mRNA | decreases expression | 16847310
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Capsaicin |
18.02 | 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
18.02 | 18769834 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
18.02 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
18.02 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
triphenyltin hydroxide |
18.02 | 17619067 |
MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
8.23 | 18769834 |
MESH:D000015 |
Abnormalities, Multiple |
|
Vitamin A |
8.23 | 10992263 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.73 | 18287403 |
MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
5.43 | 16232082 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
9.17 | 17505938 |
MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
9.17 | 18769834 16185265 |
MESH:D058186 |
Acute Kidney Injury |
|
Capsaicin |
3.79 | 18460982 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
6.47 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
6.47 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
10.20 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
10.20 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
10.20 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
10.20 | 10697514 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
10.20 | 16537180 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
7.97 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
7.97 | 6695378 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
7.97 | 11497255 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
12.48 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
12.48 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
12.48 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
3.85 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.05 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Lindane |
6.24 | 12661182 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
6.24 | 11874814 |
OMIM:607154 |
ALLERGIC RHINITIS |
|
Etodolac |
5.04 | 16979129 |
MESH:D000505 |
Alopecia |
|
Capsaicin |
7.27 | 17569567 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
7.27 | 15955085 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
4.52 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
3.66 | 17627676 15579461 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
3.66 | 19621015 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
10.75 | 11748828 |
MESH:D000740 |
Anemia |
|
Vitamin A |
10.75 | 16960172 |
MESH:D000740 |
Anemia |
|
Zymosan |
10.75 | 18664788 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.69 | 11369114 17661222 14761424 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Vitamin A |
4.05 | 16960172 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
2.99 | 10982225 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
4.05 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
8.99 | 19183758 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
8.99 | 10388637 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
7.20 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
7.20 | 11256880 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
4.32 | 2160914 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
12.79 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
12.79 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
12.79 | 16412693 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
12.79 | 15944321 16872482 15142272 15188379 17659584 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
3.79 | 11248219 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
3.79 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.05 | 16456186 |
MESH:D001249 |
Asthma |
|
Vitamin A |
4.05 | 16732791 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Fatty Acids, Omega-3 |
4.21 | 18448859 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.36 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Docosahexaenoic Acids |
2.36 | 18582451 |
MESH:D001321 |
Autistic Disorder |
|
Fatty Acids, Omega-3 |
2.36 | 16920077 |
MESH:D001321 |
Autistic Disorder |
|
Glutathione |
2.36 | 19056591 16917939 19267885 18929414 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.60 | 16935849 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.16 | 10684365 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.16 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
20.83 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Clofibrate |
20.83 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
20.83 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
20.83 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
20.83 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
2.94 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.17 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.38 | 16183116 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.11 | 11985600 |
MESH:D001919 |
Bradycardia |
|
Capsaicin |
4.23 | 18207255 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
4.17 | 11481608 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.48 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.44 | 15665606 15845082 15380490 |
MESH:D002545 |
Brain Ischemia |
|
beta Carotene |
12.50 | 16157235 |
MESH:D002545 |
Brain Ischemia |
|
Capsaicin |
12.50 | 19211983 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
12.50 | 12524144 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
3.62 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
10.09 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
10.09 | 17162533 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
10.09 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
10.09 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
10.09 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
10.09 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
10.09 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
10.09 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
LG 100268 |
10.09 | 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
Lindane |
10.09 | 14688026 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
10.09 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Retinoids |
10.09 | 17368321 19340624 17491551 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
10.09 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
10.09 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
10.24 | 16813970 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Vitamin A |
10.24 | 17377406 17426644 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.55 | 11589617 |
MESH:D002056 |
Burns |
|
Indomethacin |
3.89 | 10459503 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
4.17 | 16537180 15625704 15141370 11239499 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.12 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.30 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid |
20.64 | 17270033 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
20.64 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
20.64 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
20.64 | 19418558 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
20.64 | 16217749 15073043 15553829 14691202 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
20.64 | 16270382 17159502 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
20.64 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
20.64 | 20935162 1701930 6705139 20007298 17173139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
20.64 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
20.64 | 1917145 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Vitamin K 2 |
20.64 | 17270033 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.15 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
3.89 | 11053908 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
4.51 | 18791128 14736730 11352223 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.02 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
5.02 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
5.02 | 17341418 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.37 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
23.31 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
23.31 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
23.31 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Glutathione |
23.31 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
23.31 | 12636206 15482327 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
23.31 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
23.31 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
23.31 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
23.31 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
1.84 | 18670907 16120746 18850075 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
5.35 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
5.35 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
14.55 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
14.55 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Aphidicolin |
14.55 | 8243401 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Clofibrate |
14.55 | 1399818 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
14.55 | 19524636 20056578 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.43 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
10.20 | 16154183 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
10.20 | 16129372 |
MESH:D015362 |
Child Nutrition Disorders |
|
Vitamin A |
4.62 | 16153327 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.44 | 16835633 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
4.32 | 11181007 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
18.37 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
18.37 | 15861022 17333356 16105132 17110522 11677210 17681005 16919318 |
MESH:D002779 |
Cholestasis |
|
Lithocholic Acid |
18.37 | 19965603 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
18.37 | 19176532 |
MESH:D002779 |
Cholestasis |
|
Vitamin A |
18.37 | 16175620 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.30 | 16461808 |
MESH:D002869 |
Chromosome Aberrations |
|
triphenyltin hydroxide |
6.15 | 10477351 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
10.54 | 16354765 15340226 8697196 12621046 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
10.54 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
triphenyltin hydroxide |
10.54 | 17619067 |
MESH:D002972 |
Cleft Palate |
|
Vitamin A |
10.54 | 16054864 |
MESH:D003092 |
Colitis |
|
Selenium |
6.80 | 17936198 |
MESH:D003092 |
Colitis |
|
Tretinoin |
6.80 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid |
8.47 | 16596235 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
8.47 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Etodolac |
8.47 | 16004971 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
8.47 | 15786552 11260862 15963497 15637740 15936596 15625704 |
MESH:D003110 |
Colonic Neoplasms |
|
Vitamin A |
8.47 | 17219422 16267017 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.85 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Etodolac |
3.85 | 11076880 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
3.85 | 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
3.85 | 11197048 18059344 12606626 17054584 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.34 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.38 | 12609071 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
4.86 | 17302372 |
MESH:D003371 |
Cough |
|
Capsaicin |
4.33 | 10350223 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
11.34 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
11.34 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
11.34 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
11.34 | 18769834 9879862 |
MESH:D019465 |
Craniofacial Abnormalities |
|
nitrofen |
11.34 | 11405365 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
11.34 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
11.34 | 8800419 14991402 10589399 9125849 17551590 16925845 9142499 9211117 9224671 9664655 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin A |
11.34 | 10992263 |
MESH:D003550 |
Cystic Fibrosis |
|
Docosahexaenoic Acids |
6.88 | 19747007 |
MESH:D003550 |
Cystic Fibrosis |
|
Glutathione |
6.88 | 19747007 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.31 | 15213294 |
MESH:D003872 |
Dermatitis |
|
Benzene |
3.95 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
4.45 | 12868966 11298694 18759878 14531868 11906362 8970840 2524372 8156756 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
4.45 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
1.96 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
2.72 | 3621924 2952479 |
MESH:D003920 |
Diabetes Mellitus |
|
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate |
7.86 | 15997096 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
7.86 | 17446233 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
triphenyltin chloride |
4.78 | 9202216 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Vitamin A |
3.18 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
alpha-Tocopherol |
7.84 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
7.84 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
7.84 | 17107852 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
troglitazone |
7.84 | 16023994 |
MESH:D003925 |
Diabetic Angiopathies |
|
troglitazone |
4.82 | 12601628 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.67 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
5.67 | 7237001 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
5.67 | 7237001 7907874 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
8.31 | 6679447 9328219 16192314 6482804 8291058 11289319 18648102 9022650 18289764 7440962 9653073 1440618 18692083 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.31 | 11529661 12958197 16781746 11287661 14550746 10915739 12594235 12392966 11743745 16177239 19923254 19085960 12153990 15968718 19164858 16227642 14725611 14986274 12540782 16109766 18713872 11834606 2444490 19370779 10663392 19416960 19739265 16393943 11739529 11461765 15619225 18071297 12705907 17522070 10774834 11421492 19420014 17906064 16485898 16081117 17562736 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
8.31 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.31 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
troglitazone |
8.31 | 14986274 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.24 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.11 | 11462148 |
MESH:D015352 |
Dry Eye Syndromes |
|
Vitamin A |
4.96 | 16146918 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.31 | 18446180 17190690 18043480 16133044 12774134 16326151 |
MESH:D004381 |
Duodenal Ulcer |
|
Capsaicin |
7.02 | 11535926 10671773 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
7.02 | 17045617 17202747 17329845 10671773 16699067 11991626 17151854 11595431 11535926 11595415 17351913 |
MESH:D050171 |
Dyslipidemias |
|
Clofibrate |
6.66 | 16707586 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
6.66 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.22 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin A |
4.77 | 9068938 |
MESH:D004480 |
Ectromelia |
|
Vitamin A |
4.97 | 16054864 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.66 | 12438553 |
MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
33.56 | 8273558 |
MESH:D004487 |
Edema |
|
Dexamethasone |
33.56 | 19703484 |
MESH:D004487 |
Edema |
|
Indomethacin |
33.56 | 7990266 7907874 8273558 16100529 8985016 10653021 19703484 |
MESH:D004487 |
Edema |
|
L 663536 |
33.56 | 7990266 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
33.56 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
33.56 | 12083418 |
MESH:D004487 |
Edema |
|
rosiglitazone |
33.56 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
33.56 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
33.56 | 9599246 11698051 7812673 16716910 15177302 8113982 8273558 |
MESH:D004487 |
Edema |
|
Zymosan |
33.56 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.12 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.12 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
15-deoxy-delta(12,14)-prostaglandin J2 |
15.51 | 16844232 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
15.51 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
15.51 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
15.51 | 17692515 |
MESH:D018159 |
Endolymphatic Hydrops |
|
Dimethyl Sulfoxide |
5.71 | 20641076 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
2.51 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
11.02 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
11.02 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
11.02 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
7.88 | 18509659 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
7.88 | 15821434 15328337 17637181 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
3.90 | 17763956 10567023 16328016 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
4.16 | 17980183 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
3.25 | 11298111 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.29 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.03 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.39 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
2.82 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.43 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.19 | 3659116 |
MESH:D004935 |
Esophageal Diseases |
|
Capsaicin |
4.87 | 19566590 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.42 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.42 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
10.42 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
10.42 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
10.42 | 11005569 |
MESH:D004942 |
Esophagitis, Peptic |
|
Bile Acids and Salts |
5.70 | 11346197 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
6.62 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
6.62 | 16938888 9664655 |
MESH:D015785 |
Eye Diseases, Hereditary |
|
Retinoids |
5.18 | 16968212 |
MESH:D005234 |
Fatty Liver |
|
3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid |
25.50 | 21071580 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
25.50 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Clofibrate |
25.50 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
25.50 | 18296743 17967931 19004024 19551842 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
25.50 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
25.50 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
25.50 | 19196556 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
8.44 | 11858732 |
MESH:D005313 |
Fetal Death |
|
triphenyltin hydroxide |
8.44 | 2087686 |
MESH:D005327 |
Fetal Resorption |
|
Vitamin A |
4.51 | 16054864 |
MESH:D005334 |
Fever |
|
Indomethacin |
6.89 | 10431976 11852909 17627676 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
6.89 | 9205823 11852909 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.16 | 6705139 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
4.06 | 10962813 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
14.55 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
14.55 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.55 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.55 | 17994277 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
4.32 | 11298111 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.46 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
8.32 | 16983495 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
8.32 | 15046732 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
3.84 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Capsaicin |
15.93 | 18405923 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
15.93 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
15.93 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Okadaic Acid |
15.93 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
15.93 | 17312396 |
MESH:D005910 |
Glioma |
|
Indomethacin |
2.82 | 16487511 18371953 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.31 | 11124998 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
3.59 | 11849393 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.25 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.74 | 10696789 |
MESH:D006073 |
Gout |
|
Indomethacin |
4.51 | 11248219 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
9.63 | 15482327 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Retinoids |
9.63 | 17368321 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
9.63 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Dimethyl Sulfoxide |
4.44 | 20641076 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.30 | 16084493 |
MESH:D006356 |
Heartburn |
|
Capsaicin |
4.87 | 19566590 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
15.54 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
nitrofen |
15.54 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
15.54 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
15.54 | 9664655 14991402 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin A |
15.54 | 16080930 10992263 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
5.02 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
5.02 | 17162251 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
3.87 | 16183116 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.64 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.57 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
3.81 | 15633222 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
6.99 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
6.99 | 19110552 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
3.88 | 15135802 |
MESH:D006529 |
Hepatomegaly |
|
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
18.61 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
18.61 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
18.61 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
18.61 | 19176532 16221962 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
18.61 | 15340226 16120746 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
7.59 | 7520565 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
nitrofen |
7.59 | 16292651 11409163 15578192 15707848 10370016 12759764 16863852 10898222 11057544 16490937 15764645 10898224 10646786 12904592 9859898 15793718 7576705 15756563 17618886 8863223 10359170 18958481 15185205 9575882 10693666 7760232 11051153 11076806 10541330 17245593 18280291 16720372 9476886 15088113 10370017 15136996 16473863 12194112 16080930 17270546 11588001 18280292 12547725 7520565 12407540 12505043 12746050 11685700 11584395 9698600 11329586 12021965 9473106 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin A |
7.59 | 16877224 17436238 16863852 16292552 15707848 16490937 |
MESH:D015658 |
HIV Infections |
|
beta Carotene |
5.56 | 16960176 |
MESH:D015658 |
HIV Infections |
|
Vitamin A |
5.56 | 16960176 |
MESH:D006679 |
HIV Seropositivity |
|
Vitamin A |
4.76 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.46 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.19 | 15340226 18606429 16959395 8697196 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
21.66 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Capsaicin |
21.66 | 17043245 17434803 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
21.66 | 12727271 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
21.66 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
21.66 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
21.66 | 16870215 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
4.86 | 17883296 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
2.84 | 21332399 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
4.17 | 12524144 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.75 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
7.44 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
triphenyltin hydroxide |
7.44 | 6714370 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
6.76 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
6.76 | 17546600 |
MESH:D006951 |
Hyperlipoproteinemias |
|
Fatty Acids, Unsaturated |
5.42 | 18435438 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.12 | 15034207 |
MESH:D006973 |
Hypertension |
|
Benzene |
6.31 | 17940673 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
6.31 | 17042910 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
6.31 | 18670907 18850075 |
MESH:D006976 |
Hypertension, Pulmonary |
|
L 663536 |
4.53 | 14726295 |
MESH:D006986 |
Hypervitaminosis A |
|
Vitamin A |
5.31 | 16054864 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
2.99 | 16945680 16569931 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.17 | 18306037 10574470 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
4.51 | 10647630 10651667 16133968 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
4.52 | 16133044 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
3.58 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.68 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
7.69 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
7.69 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.69 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
37.46 | 8273558 |
MESH:D007249 |
Inflammation |
|
Capsaicin |
37.46 | 16956363 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
37.46 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
37.46 | 20412841 |
MESH:D007249 |
Inflammation |
|
Fatty Acids, Omega-3 |
37.46 | 17296493 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
37.46 | 12568917 7812673 3291741 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
37.46 | 9205823 17237260 12878042 17963957 17255318 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
37.46 | 12083418 |
MESH:D007249 |
Inflammation |
|
Progesterone |
37.46 | 15869954 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
37.46 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
37.46 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
37.46 | 15177302 7812673 7562506 11698051 8273558 |
MESH:D007249 |
Inflammation |
|
Zymosan |
37.46 | 11289658 8014878 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
3.35 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
12.71 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
12.71 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.71 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
12.71 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
7.18 | 18236018 17329856 11686837 15831440 15610444 11713966 10210152 17994277 11855677 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
7.18 | 17994277 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
11.36 | 15241188 |
MESH:D019586 |
Intracranial Hypertension |
|
Vitamin A |
11.36 | 15955940 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
3.85 | 17255318 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.00 | 17553498 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.16 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
7.40 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
7.40 | 17551590 15992940 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.17 | 18306037 10574470 16133968 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
4.80 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.93 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
6.93 | 17190690 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.93 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.13 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.29 | 6582329 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.21 | 10320625 11703811 12228301 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
7.62 | 15070760 |
MESH:D007938 |
Leukemia |
|
Benzene |
7.62 | 14694614 18335105 15935818 17119257 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
7.62 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
troglitazone |
5.29 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
7.53 | 17077332 12560223 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Docosahexaenoic Acids |
7.53 | 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
9.00 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
9.00 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
6.36 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
6.36 | 16572323 10785260 15631656 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
16.70 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
16.70 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
Retinoids |
16.70 | 16482212 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
16.70 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
6.75 | 17050201 16968895 20471514 16467208 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
6.75 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
6.75 | 18360721 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
6.75 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
5.62 | 15213294 17649720 17869043 16330433 12679006 19642359 16966277 17712046 15622746 16823087 19225113 16112521 19075265 15336539 16891316 12712474 12018890 17217047 11161223 16331271 11468182 15748426 9834237 17107899 19035177 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
5.62 | 17368321 16331271 16935935 17294898 16891316 16823087 19029980 15748426 17301526 16140955 19075265 17339181 19225113 19035177 12679006 17107899 17506722 19642359 17361223 17217047 17649720 9834237 16788101 17712046 16766008 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.55 | 16882451 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
4.52 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
4.86 | 17980183 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
3.86 | 15821434 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.19 | 16707609 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.39 | 8812269 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
6.35 | 9224671 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Vitamin A |
6.35 | 16054864 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
4.86 | 11479899 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
8.04 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
8.04 | 21047994 |
MESH:D008103 |
Liver Cirrhosis |
|
Vitamin A |
8.04 | 16256175 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.61 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
12.09 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethyl Sulfoxide |
12.09 | 11682029 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
12.09 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
12.09 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
12.09 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
12.09 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
12.09 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
12.09 | 16248980 18397230 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin A |
12.09 | 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
14.47 | 12587719 12969438 11587558 19014921 16610002 19784758 19460945 16611625 |
MESH:D008107 |
Liver Diseases |
|
Capsaicin |
14.47 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Docosahexaenoic Acids |
14.47 | 17056761 |
MESH:D008107 |
Liver Diseases |
|
Lindane |
14.47 | 1715830 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
14.47 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Sulfonamides |
14.47 | 14986274 |
MESH:D008107 |
Liver Diseases |
|
Vitamin A |
14.47 | 16175620 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Vitamin A |
4.34 | 16762690 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.49 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid |
25.16 | 21071580 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
25.16 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
25.16 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
25.16 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Methapyrilene |
25.16 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
25.16 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
25.16 | 19482888 19812893 15975961 8742319 21047994 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
25.16 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
25.16 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
25.16 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
19.36 | 6587162 1399818 598648 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
19.36 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
19.36 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta Carotene |
19.36 | 17113696 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
19.36 | 18308698 17172636 1399818 2563599 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
19.36 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Vitamin A |
19.36 | 17113696 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.69 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
nitrofen |
9.06 | 9859898 16863852 9614859 17245593 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
9.06 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin A |
9.06 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
3.96 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
6.61 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
6.61 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
9-deoxy-delta-9-prostaglandin D2 |
23.28 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
23.28 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
alpha-Tocopherol |
23.28 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
23.28 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
23.28 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
23.28 | 18520028 18569708 17053015 18816296 6695378 20464547 20869020 20064080 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
beta Carotene |
23.28 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
23.28 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
23.28 | 11497255 16537180 11053908 |
MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
23.28 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
L 663536 |
23.28 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
23.28 | 15276417 17306315 17077188 16712894 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
23.28 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
23.28 | 11807781 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Rifampin |
5.29 | 11422169 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Rifampin |
3.67 | 11422169 |
MESH:D008223 |
Lymphoma |
|
Benzene |
3.11 | 17584886 17119257 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
3.62 | 12562636 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
19.43 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
19.43 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
LG 100268 |
19.43 | 12374698 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
19.43 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
19.43 | 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
19.43 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
19.43 | 8985016 |
MESH:D008415 |
Mastocytosis |
|
Retinoids |
5.75 | 16953078 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.37 | 17453147 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
5.45 | 16270382 |
MESH:D008545 |
Melanoma |
|
Isotretinoin |
5.45 | 17237267 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.45 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.45 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
2.75 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.60 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
4.91 | 16966607 18303189 16166281 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
4.91 | 15107826 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
3.67 | 17261469 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
3.05 | 11903285 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
10.60 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
10.60 | 16274795 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
10.60 | 12636206 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
15.94 | 14977855 11468182 19549372 19417148 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
15.94 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
Capsaicin |
15.94 | 17505005 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
15.94 | 15744524 15867202 16118317 |
MESH:D009101 |
Multiple Myeloma |
|
Vitamin A |
15.94 | 16374440 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.43 | 12879239 15259001 15241586 18160304 12130978 10479408 15213630 17724436 15834315 10890648 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.69 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
triphenyltin hydroxide |
5.38 | 17619067 |
MESH:D009164 |
Mycobacterium Infections |
|
Rifampin |
4.70 | 18474467 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
3.82 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
9.15 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
9.15 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
9.15 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
alpha-Tocopherol |
4.68 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
4.68 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.33 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.27 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
3.64 | 17484760 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.16 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
4.50 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
4.50 | 11053908 16537180 11239499 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
19.63 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
19.63 | 11141357 |
MESH:D009369 |
Neoplasms |
|
beta Carotene |
19.63 | 17051425 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
19.63 | 15958647 17353921 |
MESH:D009369 |
Neoplasms |
|
Lindane |
19.63 | 12807735 16818664 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
19.63 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
19.63 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
19.63 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
6.58 | 15625704 10663608 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
6.58 | 20056578 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.05 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
11.77 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
11.77 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
11.77 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
20.60 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
20.60 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
20.60 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
20.60 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
20.60 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Vitamin A |
20.60 | 17400914 |
MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
3.54 | 17368321 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
6.06 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
6.06 | 12349958 |
MESH:D020078 |
Neurogenic Inflammation |
|
Capsaicin |
4.31 | 17961222 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
4.84 | 16303764 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Clofibrate |
9.34 | 9802331 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
9.34 | 9802331 |
MESH:D009765 |
Obesity |
|
Capsaicin |
5.72 | 19056576 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
5.72 | 17217161 20518802 20132043 21332399 11836018 18674790 19632207 18457598 16723640 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
5.72 | 20558911 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
4.32 | 6374098 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
6.70 | 4026338 6482804 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
6.70 | 15612468 17178637 15913788 17119257 15727169 15935809 16737584 15576619 17479406 |
MESH:D009845 |
Oligospermia |
|
triphenyltin hydroxide |
5.35 | 16806747 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.16 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
3.10 | 7009135 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.53 | 17016548 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.15 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
14.11 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
14.11 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
14.11 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
14.11 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
14.11 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
14.11 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
10.47 | 16870215 |
MESH:D010146 |
Pain |
|
Capsaicin |
10.47 | 17043245 17084039 17434803 19081190 16996476 18987195 |
MESH:D010146 |
Pain |
|
Indomethacin |
10.47 | 17440234 13679232 3291741 17627676 |
MESH:D010146 |
Pain |
|
Tretinoin |
10.47 | 16870215 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
3.83 | 18702446 12538197 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
15.30 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
15.30 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
L 663536 |
15.30 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
15.30 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
15.30 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
15.30 | 15976015 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
3.16 | 17883296 15028970 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
2.90 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
6.70 | 7296757 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
6.70 | 8330346 12065085 18404319 18922899 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.38 | 19927285 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
4.86 | 16537180 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.44 | 11124998 12911755 16140633 15824117 11445065 15451049 16510128 11181820 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
3.61 | 16190885 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
3.38 | 12349958 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
4.86 | 11903285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.39 | 12520081 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.31 | 11148446 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
4.06 | 17225004 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
4.07 | 17826846 11985352 19088179 15259001 19641140 18760300 15979727 14761945 18977430 18557954 17371808 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.62 | 6228378 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.03 | 15087411 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.07 | 10923243 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
8.35 | 12224865 11605937 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
8.35 | 12504350 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.15 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.76 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
2.90 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.01 | 21297632 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.30 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
16.53 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
16.53 | 18769834 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
16.53 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
16.53 | 11896295 11118676 11399792 11222880 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
3.94 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
3.44 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 15318950 |
MESH:D011471 |
Prostatic Neoplasms |
|
AGN 194204 |
2.44 | 16000583 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.44 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.44 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.44 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.44 | 16289102 15754350 12479363 18247401 16644109 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.44 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Lindane |
2.44 | 14688026 12661182 |
MESH:D011471 |
Prostatic Neoplasms |
|
Retinoids |
2.44 | 16166285 16724957 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.44 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
6.76 | 11849393 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
6.76 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
7.34 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
L 663536 |
7.34 | 17827870 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
3.64 | 12752131 |
MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
5.08 | 18769834 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
3.95 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
3.95 | 10548101 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
alpha-Tocopherol |
5.14 | 14606601 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
7.05 | 17322281 17365031 17975199 15814490 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
7.05 | 16324872 17997886 |
MESH:D011658 |
Pulmonary Fibrosis |
|
troglitazone |
7.05 | 18162602 |
MESH:D015427 |
Reperfusion Injury |
|
Capsaicin |
5.17 | 18460982 19211983 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.17 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
6.69 | 11700416 18379247 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
6.69 | 11700416 |
MESH:D012127 |
Respiratory Distress Syndrome, Newborn |
|
Vitamin A |
4.96 | 16877224 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.13 | 10835634 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.25 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
15.98 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
9-cis-retinal |
15.98 | 17003450 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
15.98 | 16303925 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
15.98 | 16458197 |
MESH:D012174 |
Retinitis Pigmentosa |
|
alpha-Tocopherol |
3.66 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.32 | 16116481 16283617 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.48 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.16 | 16646077 |
MESH:D020426 |
Sciatic Neuropathy |
marker/mechanism |
|
| 16782282 |
MESH:D012640 |
Seizures |
|
Lindane |
6.72 | 7539098 15475178 12842176 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
6.72 | 3137016 11442880 16876388 4039156 |
MESH:D012640 |
Seizures |
|
Sulfonamides |
6.72 | 20420384 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
3.98 | 6407741 |
MESH:D018805 |
Sepsis |
|
Zymosan |
3.94 | 11441115 |
MESH:D012871 |
Skin Diseases |
|
Vitamin A |
3.07 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
27.47 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
27.47 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Okadaic Acid |
27.47 | 12628509 |
MESH:D012878 |
Skin Neoplasms |
|
Retinoids |
27.47 | 17538947 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
27.47 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
27.47 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
27.47 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
27.47 | 12065085 18404319 8985016 8330346 11807781 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
27.47 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.09 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.45 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.11 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
beta Carotene |
12.41 | 17638125 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
12.41 | 15472012 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
12.41 | 16113693 16280098 10192188 16184426 18209964 17160473 17207306 18545984 17638125 15038085 10215738 10486359 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
8.07 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
8.07 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
8.07 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Docosahexaenoic Acids |
8.07 | 19015929 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
8.07 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
8.07 | 17261132 |
MESH:D013274 |
Stomach Neoplasms |
|
troglitazone |
8.07 | 15930296 |
MESH:D013276 |
Stomach Ulcer |
|
beta Carotene |
7.99 | 12500499 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
7.99 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
7.99 | 17918041 16169175 18209962 16934674 17135157 14567935 17895592 17627676 18726076 18431645 16150113 12467913 10878458 16397915 11906479 18237397 12787963 11595431 10750652 18193104 1323529 15255614 16631530 15104355 10423059 17657623 18543354 18087811 17977527 11595415 17654042 12500499 16755016 12498302 11729361 18299717 11523592 15138204 11145282 16252198 18181030 12077510 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.16 | 16684133 16045194 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Capsaicin |
4.87 | 17997062 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.42 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
2.84 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.43 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.12 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.05 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
19.43 | 6582329 6587162 7505956 1399818 3712494 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
19.43 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
19.43 | 14736730 11352223 18791128 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
19.43 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Retinoids |
19.43 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
19.43 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.04 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.13 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Rifampin |
6.47 | 15236969 18397238 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
6.47 | 16040207 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
4.06 | 10574470 17380554 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.29 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
11.29 | 12845720 11780464 20435036 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.29 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
11.29 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
11.29 | 11723127 16452187 17306315 16712894 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.21 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
11.67 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
11.67 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
11.67 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.15 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
6.93 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
6.93 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.76 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
9.46 | 1336536 |
MESH:D014605 |
Uveitis |
|
Zymosan |
9.46 | 11006244 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.59 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.74 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
2.78 | 14671159 15869587 |
MESH:D014802 |
Vitamin A Deficiency |
|
Vitamin A |
4.49 | 16146918 16960172 16175781 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.26 | 16761959 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
3.90 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.39 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.01 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.24 | 16287080 |